Skip to main content

AGMB · Agomab Therapeutics NV · Holdings

Track AGMB — free
$13.06 -0.88 (-6.31%) At close · Sep 11
Market Cap
$643.18M
Shares
49.25M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 34
Total Value: $336,902,146
Total Shares: 25,955,482

Institutional Ownership Trend

2 quarters

Holder Concentration

Across 34 13F filers · Δ vs Mar 31, 2026
Top Holder
19.8%
Mar 2026 → Jun 2026 · range 19.8% – 22.0%
−2.2 pts
Top 5
58.5%
Mar 2026 → Jun 2026 · range 58.5% – 60.2%
−1.7 pts
Top 10
88.3%
Mar 2026 → Jun 2026 · range 87.9% – 88.3%
+0.4 pts
HHI
974
Mar 2026 → Jun 2026 · range 974 – 1,045
Broadly held−72

Quarterly Activity

vs Mar 31, 2026
New
9
Increased
4
Decreased
6
Sold Out
7
Unchanged
15
Holder count: +2
Institutional value: +37.5%
Shares held: +11.1%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 34 of 34
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 2020932 CUSIP 00860C102 13F (30d) 24 filings 24 filers Visit website Investor relations